Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemofarm is a leading pharmaceutical company based in Serbia and a prominent member of the STADA Group. The company specializes in the development, manufacturing, and marketing of a wide range of generic pharmaceuticals, including prescription drugs, over-the-counter (OTC) products, and dietary supplements. With a strong manufacturing footprint in Southeast Europe, Hemofarm operates several GMP-certified facilities and serves as a key production hub for the STADA Group's global operations. Its portfolio covers diverse therapeutic areas such as cardiovascular health, infectious diseases, and central nervous system disorders, maintaining a dominant market position in the Western Balkans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemopharm.